Literature DB >> 18305197

Crystal structure of enoyl-acyl carrier protein reductase (FabK) from Streptococcus pneumoniae reveals the binding mode of an inhibitor.

Jun Saito1, Mototsugu Yamada, Takashi Watanabe, Maiko Iida, Hideo Kitagawa, Sho Takahata, Tomohiro Ozawa, Yasuo Takeuchi, Fukuichi Ohsawa.   

Abstract

Enoyl-acyl carrier protein (ACP) reductases are critical for bacterial type II fatty acid biosynthesis and thus are attractive targets for developing novel antibiotics. We determined the crystal structure of enoyl-ACP reductase (FabK) from Streptococcus pneumoniae at 1.7 A resolution. There was one dimer per asymmetric unit. Each subunit formed a triose phosphate isomerase (TIM) barrel structure, and flavin mononucleotide (FMN) was bound as a cofactor in the active site. The overall structure was similar to the enoyl-ACP reductase (ER) of fungal fatty acid synthase and to 2-nitropropane dioxygenase (2-ND) from Pseudomonas aeruginosa, although there were some differences among these structures. We determined the crystal structure of FabK in complex with a phenylimidazole derivative inhibitor to envision the binding site interactions. The crystal structure reveals that the inhibitor binds to a hydrophobic pocket in the active site of FabK, and this is accompanied by induced-fit movements of two loop regions. The thiazole ring and part of the ureido moiety of the inhibitor are involved in a face-to-face pi-pi stacking interaction with the isoalloxazine ring of FMN. The side-chain conformation of the proposed catalytic residue, His144, changes upon complex formation. Lineweaver-Burk plots indicate that the inhibitor binds competitively with respect to NADH, and uncompetitively with respect to crotonoyl coenzyme A. We propose that the primary basis of the inhibitory activity is competition with NADH for binding to FabK, which is the first step of the two-step ping-pong catalytic mechanism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18305197      PMCID: PMC2271168          DOI: 10.1110/ps.073288808

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  43 in total

1.  Crystallization and preliminary X-ray analysis of enoyl-acyl carrier protein reductase (FabK) from Streptococcus pneumoniae.

Authors:  Jun Saito; Mototsugu Yamada; Takashi Watanabe; Hideo Kitagawa; Yasuo Takeuchi
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-05-31

2.  Structure of fungal fatty acid synthase and implications for iterative substrate shuttling.

Authors:  Simon Jenni; Marc Leibundgut; Daniel Boehringer; Christian Frick; Bohdan Mikolásek; Nenad Ban
Journal:  Science       Date:  2007-04-13       Impact factor: 47.728

3.  In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea.

Authors:  Jong Hwa Yum; Chang Ki Kim; Dongeun Yong; Kyungwon Lee; Yunsop Chong; Cheol Min Kim; Jeong Mi Kim; Seonggu Ro; Joong Myung Cho
Journal:  Antimicrob Agents Chemother       Date:  2007-04-09       Impact factor: 5.191

4.  Kinetic characterization of the rotenone-insensitive internal NADH: ubiquinone oxidoreductase of mitochondria from Saccharomyces cerevisiae.

Authors:  I Velázquez; J P Pardo
Journal:  Arch Biochem Biophys       Date:  2001-05-01       Impact factor: 4.013

5.  Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents.

Authors:  M A Seefeld; W H Miller; K A Newlander; W J Burgess; D J Payne; S F Rittenhouse; T D Moore; W E DeWolf; P M Keller; X Qiu; C A Janson; K Vaidya; A P Fosberry; M G Smyth; D D Jaworski; C Slater-Radosti; W F Huffman
Journal:  Bioorg Med Chem Lett       Date:  2001-09-03       Impact factor: 2.823

6.  4-Pyridone derivatives as new inhibitors of bacterial enoyl-ACP reductase FabI.

Authors:  Hideo Kitagawa; Ko Kumura; Sho Takahata; Maiko Iida; Kunio Atsumi
Journal:  Bioorg Med Chem       Date:  2006-10-13       Impact factor: 3.641

7.  Discovery of a novel and potent class of FabI-directed antibacterial agents.

Authors:  David J Payne; William H Miller; Valerie Berry; John Brosky; Walter J Burgess; Emile Chen; Walter E DeWolf; Andrew P Fosberry; Rebecca Greenwood; Martha S Head; Dirk A Heerding; Cheryl A Janson; Deborah D Jaworski; Paul M Keller; Peter J Manley; Terrance D Moore; Kenneth A Newlander; Stewart Pearson; Brian J Polizzi; Xiayang Qiu; Stephen F Rittenhouse; Courtney Slater-Radosti; Kevin L Salyers; Mark A Seefeld; Martin G Smyth; Dennis T Takata; Irene N Uzinskas; Kalindi Vaidya; Nicola G Wallis; Scott B Winram; Catherine C K Yuan; William F Huffman
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

8.  Phenylimidazole derivatives of 4-pyridone as dual inhibitors of bacterial enoyl-acyl carrier protein reductases FabI and FabK.

Authors:  Hideo Kitagawa; Tomohiro Ozawa; Sho Takahata; Maiko Iida; Jun Saito; Mototsugu Yamada
Journal:  J Med Chem       Date:  2007-08-22       Impact factor: 7.446

9.  Automated MAD and MIR structure solution.

Authors:  T C Terwilliger; J Berendzen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-04

10.  Relative fitness of fluoroquinolone-resistant Streptococcus pneumoniae.

Authors:  Crystal N Johnson; David E Briles; William H Benjamin; Susan K Hollingshead; Ken B Waites
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

View more
  22 in total

1.  Structural characterization of Porphyromonas gingivalis enoyl-ACP reductase II (FabK).

Authors:  Kirk E Hevener; Bernard D Santarsiero; Hyun Lee; Jesse A Jones; Teuta Boci; Michael E Johnson; Shahila Mehboob
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2018-01-26       Impact factor: 1.056

2.  Crystal structures and kinetic properties of enoyl-acyl carrier protein reductase I from Candidatus Liberibacter asiaticus.

Authors:  Ling Jiang; Zengqiang Gao; Yanhua Li; Shennan Wang; Yuhui Dong
Journal:  Protein Sci       Date:  2014-02-12       Impact factor: 6.725

3.  Purification, crystallization and preliminary X-ray diffraction analysis of enoyl-acyl carrier protein reductase (FabK) from Streptococcus mutans strain UA159.

Authors:  Tae-O Kim; Dong-Won Im; Ha Yun Jung; Seong Jung Kwon; Yong-Seok Heo
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-02-22

4.  Expression, purification and characterization of enoyl-ACP reductase II, FabK, from Porphyromonas gingivalis.

Authors:  Kirk E Hevener; Shahila Mehboob; Teuta Boci; Kent Truong; Bernard D Santarsiero; Michael E Johnson
Journal:  Protein Expr Purif       Date:  2012-07-20       Impact factor: 1.650

Review 5.  The architectures of iterative type I PKS and FAS.

Authors:  Dominik A Herbst; Craig A Townsend; Timm Maier
Journal:  Nat Prod Rep       Date:  2018-10-17       Impact factor: 13.423

6.  Rational questing for potential novel inhibitors of FabK from Streptococcus pneumoniae by combining FMO calculation, CoMFA 3D-QSAR modeling and virtual screening.

Authors:  Qingye Zhang; Chan Yu; Jun Min; Yan Wang; Jin He; Ziniu Yu
Journal:  J Mol Model       Date:  2010-09-23       Impact factor: 1.810

7.  The MUT056399 inhibitor of FabI is a new antistaphylococcal compound.

Authors:  S Escaich; L Prouvensier; M Saccomani; L Durant; M Oxoby; V Gerusz; F Moreau; V Vongsouthi; Kirsty Maher; Ian Morrissey; C Soulama-Mouze
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

8.  The genome of a Bacteroidetes inhabitant of the human gut encodes a structurally distinct enoyl-acyl carrier protein reductase (FabI).

Authors:  Christopher D Radka; Matthew W Frank; Jiangwei Yao; Jayaraman Seetharaman; Darcie J Miller; Charles O Rock
Journal:  J Biol Chem       Date:  2020-04-21       Impact factor: 5.157

9.  Triclosan resistance of Pseudomonas aeruginosa PAO1 is due to FabV, a triclosan-resistant enoyl-acyl carrier protein reductase.

Authors:  Lei Zhu; Jinshui Lin; Jincheng Ma; John E Cronan; Haihong Wang
Journal:  Antimicrob Agents Chemother       Date:  2009-11-23       Impact factor: 5.191

10.  Trapping of the Enoyl-Acyl Carrier Protein Reductase-Acyl Carrier Protein Interaction.

Authors:  Lorillee Tallorin; Kara Finzel; Quynh G Nguyen; Joris Beld; James J La Clair; Michael D Burkart
Journal:  J Am Chem Soc       Date:  2016-03-15       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.